Venmax Drugs & Pharmaceuticals Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net profit of Venmax Drugs & Pharmaceuticals declined 85.90% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 0.78 crore during the previous quarter ended March 2025. Sales rose 1093.94% to Rs 3.94 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.25 crore in the year ended March 2026 as against net loss of Rs 0.01 crore during the previous year ended March 2025. Sales rose 890.12% to Rs 8.02 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Net profit of Venmax Drugs & Pharmaceuticals reported to Rs 0.03 crore in the quarter ended December 2025 as against net loss of Rs 0.50 crore during the previous quarter ended December 2024. Sales rose 675.00% to Rs 1.55 crore in the quarter ended December 2025 as against Rs 0.20 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 February 2026.

Powered by Capital Market - Live News